Literature DB >> 6824359

Plasma exchange in pemphigus. Uncontrolled study of ten patients.

J C Roujeau, C Andre, M Joneau Fabre, P Lauret, M L Flechet, B Kalis, J Revuz, R Touraine.   

Abstract

Plasma exchange, together with oral immunosuppressive drugs and various doses of adrenal steroids, were used in the treatment of ten patients with pemphigus. Initially plasma exchange decreased the intercellular antibody (IC Ab) level in all patients and induced a clinical improvement in the conditions of eight of ten patients. This improvement was sustained for the six patients who received simultaneously 0.5 mg/kg/day or more of prednisone. Among the eight patients, four previously corticoresistant patients had perfect control of their disease. Conversely the other four patients, treated with low doses of prednisone, experienced a posttreatment rebound in IC Ab level and showed no or only transient clinical improvement. Plasma exchange may be useful in bringing corticoresistant pemphigus under control but it is not to be used without accompanying high doses of adrenal steroids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824359

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

Review 1.  Management of autoimmune skin disorders in the elderly.

Authors:  Wei Jing Loo; Nigel P Burrows
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 2.  Novel therapies for pemphigus vulgaris: an overview.

Authors:  Oliver A Perez; Timothy Patton
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Pemphigus vulgaris: a multidisciplinary approach to management.

Authors:  Christopher Vinall; Lucy Stevens; Paul McArdle
Journal:  BMJ Case Rep       Date:  2013-12-16

4.  Rituximab Therapy for Treatment of Pemphigus in Southeast Asians.

Authors:  Silada Kanokrungsee; Tanaporn Anuntrangsee; Jutamas Tankunakorn; Ploychompoo Srisuwanwattana; Poonkiat Suchonwanit; Kumutnart Chanprapaph
Journal:  Drug Des Devel Ther       Date:  2021-04-22       Impact factor: 4.162

Review 5.  Emerging treatment options for the management of pemphigus vulgaris.

Authors:  Khalaf Kridin
Journal:  Ther Clin Risk Manag       Date:  2018-04-27       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.